SS wrote: "What I don't get is that if this is a blockbuster potentially, why such a low pp? Not many drugs aren't on the radar that go into phase 3 status. So I am perplexed."

Although the Resverlogix website lists that it has "initiated" BETonMACE Phase 3, in almost all correspondence Resverlogix refers to BETonMACE as their "planned" or "proposed" Phase 3 trial. Once enrollment/dosing officially begin and the BETonMACE trial design is disclosed, then we can officially put RVX-208 into the Phase 3 category. Don said last Friday at Rodman and Renshaw that they were just a few short weeks from starting enrollment. There is a potential for a lot to happen in the next month, so hold tight!